Understanding how specific modifications in tRNA affect protein production
Determining how 2'-O-methylations in the eukaryotic anticodon loop region of tRNA are formed and how they affect translation
['FUNDING_R15'] · NORTHERN KENTUCKY UNIVERSITY · NIH-10438971
This study is looking at how certain changes in a type of molecule called transfer RNA (tRNA) help our cells make proteins, using yeast to learn more about these changes and how they might be connected to health issues like intellectual disabilities and metabolic disorders.
Quick facts
| Phase | ['FUNDING_R15'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | NORTHERN KENTUCKY UNIVERSITY (nih funded) |
| Locations | 1 site (HIGHLAND HEIGHTS, UNITED STATES) |
| Trial ID | NIH-10438971 on ClinicalTrials.gov |
What this research studies
This research investigates the role of specific chemical modifications in transfer RNA (tRNA) that are crucial for the translation process, which converts genetic information into proteins. By using yeast as a model organism, the study aims to uncover how these modifications are formed and their impact on cellular function. The research will focus on two proteins, Trm732 and Trm734, which are involved in creating these modifications and are linked to various human diseases, including intellectual disabilities and metabolic disorders. The findings could enhance our understanding of how defects in tRNA modifications contribute to disease.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with neurological disorders or metabolic conditions associated with tRNA modification defects.
Not a fit: Patients without any known genetic or metabolic disorders related to tRNA modifications may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new insights into the treatment of diseases linked to tRNA modification defects, potentially improving patient outcomes.
How similar studies have performed: Previous research has shown promising results in understanding tRNA modifications and their implications in various diseases, indicating that this approach has potential for success.
Where this research is happening
HIGHLAND HEIGHTS, UNITED STATES
- NORTHERN KENTUCKY UNIVERSITY — HIGHLAND HEIGHTS, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: GUY, MICHAEL P. — NORTHERN KENTUCKY UNIVERSITY
- Study coordinator: GUY, MICHAEL P.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Cancers